Percutaneous Electrical Nerve Stimulation and Exercise for Shoulder Pain

César Fernández-de-las-Peñas59 enrolled

Overview

Based on the available literature, application of percutaneous electrical nerve stimulation interventions targeting peripheral nerves (also called percutaneous neuromodulation) has shown positive effects for improving pain-related and functional outcomes in musculoskeletal chronic pain. Studies investigating the use of this intervention for the shoulder are lacking.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Shoulder Pain

Interventions

Percutaneous Electrical Nerve StimulationOTHER

Application of a electrical current percutaneously (at the motor response intensity) targeting the suprascapular and axillar nerves

Placebo Percutaneous Electrical Nerve StimulationOTHER

Application of sham electrical current (no intensity) percutaneously targeting the suprascapular and axillar nerves

ExerciseOTHER

Application of three weeks of progressive exercises targeting the shoulder musculature

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Unilateral non-traumatic shoulder pain (positive painful arc during shoulder abduction and a positive Hawkins test on clinical examination) * Shoulder pain from at least 3 months * Shoulder pain of more than 3/10 points on a NPRS Exclusion Criteria: * Bilateral shoulder symptoms * Younger than 18 or older than 65 years * History of shoulder traumatisms, fractures or dislocation * Diagnosis of cervical radiculopathy or myelopathy * Previous interventions with steroid injections in the shoulder area * Comorbid medical conditions, e.g., fibromyalgia syndrome * Previous history of shoulder or neck surgery * Any type of intervention for the neck-shoulder area during the previous year * Fear to needles

Locations (1)

César Fernández-de-las-Peñas

Madrid, Rest of the World, Spain

Outcomes

Primary Outcomes

Changes in disability between baseline and follow-up periods

The Disabilities of the Arm, Shoulder and Hand (DASH) will be used to determine the disability induced by shoulder pain

Time frame: Baseline, one week after the last intervention and 1 and 3 months after the intervention

Secondary Outcomes

Changes in shoulder pain between baseline and follow-up periods

A 10-point Numerical Pain Rating Scale (NPRS; 0: no pain, 10: maximum pain) will be used to assess the patients' mean level of shoulder pain experienced in the preceding week in the shoulder area.

Time frame: Baseline, one week after the last intervention and 1 and 3 months after the intervention

Changes in sleep quality between baseline and follow-up periods

The Pittsburgh Sleep Quality Index (PSQI) will be used to evaluate the quality of sleep

Time frame: Baseline, one week after the last intervention and 1 and 3 months after the intervention

Changes in anxiety/depressive symptoms between baseline and follow-up periods

The Hospital Anxiety and Depression Scale (HADS, A: Anxiety; D: Depression) will be used to evaluate the presence of anxiety/depressive symptoms

Time frame: Baseline, one week after the last intervention and 1 and 3 months after the intervention

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.